Clinical Trial

Hypertrophic Cardiomyopathy Federated Learning Implementation Platform

Study acronym: HCM FLIP
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2024 (before its estimated January 2026 completion). Its status may not reflect the trial's current state.
Summary
HCM FLIP study is a two-phase protocol focusing on the detection of Hypertrophic Cardiomyopathy using Electrocardiograms and Echocardiograms through Federated Learning.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-06-13; most recent amendment 2024-08-05.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-07-31
Trial Details
NCT Number NCT06461468
Lead Sponsor American Heart Association
Conditions Hypertrophic Cardiomyopathy
Enrollment 1,000 participants
Start Date 2024-06-05
Primary Completion 2026-01 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-06